-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
315 2021，。
，
312，《2021》（《》），，。
《》，、、，。、，、、、。
，《》，，，。，、，。
，《》，、、，，。
，
—，，52021。，，。
5，《2021GSP》。，20212021。
《2021》，“”，，、，、，。
，，、、，“”，，。
，
，，。：
：；、、。11：
1、（、、、）；
2、（、、），、GSP；
3、、、 ；《》《》、《》；，；
4、、；；
5.
The company's cold chain drug management, whether the drug storage and transportation records are complete and true; whether the drug storage, transportation, and temperature and humidity monitoring are not performed in accordance with regulations; whether the temperature and humidity data of cold storage and refrigerated trucks can be uploaded in real time;
The company's cold chain drug management, whether the drug storage and transportation records are complete and true; whether the drug storage, transportation, and temperature and humidity monitoring are not performed in accordance with regulations; whether the temperature and humidity data of cold storage and refrigerated trucks can be uploaded in real time;
6.
Whether to falsify the source of drug purchases, fabricate the flow of drug sales, tamper with the computer system, temperature and humidity monitoring system data, conceal the real drug purchase and sale records, bills, vouchers, data, etc.
, the drug purchase and sale records are incomplete, untrue, and business operations cannot be performed Retrospective
Whether to falsify the source of drug purchases, fabricate the flow of drug sales, tamper with the computer system, temperature and humidity monitoring system data, conceal the real drug purchase and sale records, bills, vouchers, data, etc.
, the drug purchase and sale records are incomplete, untrue, and business operations cannot be performed Retrospective
7.
When purchasing and selling drugs, certificates (licenses), tickets (invoices, bills accompanying the goods), accounts (physical accounts, financial accounts), goods (physical drugs), and payments (payments) cannot correspond to each other; the drugs are not in the warehouse , Set up off-book accounts, drugs are not included in the enterprise quality management system, use bank personal accounts for business transactions, etc.
;
When purchasing and selling drugs, certificates (licenses), tickets (invoices, bills accompanying the goods), accounts (physical accounts, financial accounts), goods (physical drugs), and payments (payments) cannot correspond to each other; the drugs are not in the warehouse , Set up off-book accounts, drugs are not included in the enterprise quality management system, use bank personal accounts for business transactions, etc.
;
8.
Whether the drug is stored in a place other than the approved address; whether the registered address, business method, and business scope are sold without authorization;
Whether the drug is stored in a place other than the approved address; whether the registered address, business method, and business scope are sold without authorization;
9.
Failing to monitor the temperature and humidity of the storage and transportation of drugs in accordance with regulations;
Failing to monitor the temperature and humidity of the storage and transportation of drugs in accordance with regulations;
10.
Retail companies have problems selling prescription drugs and recalling drugs in violation of regulations;
Retail companies have problems selling prescription drugs and recalling drugs in violation of regulations;
11.
Other violations of laws and regulations.
Other violations of laws and regulations.
Shanxi: Pharmaceutical retail companies focus on prescription drugs, Chinese herbal medicines, and cold chain drugs.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store drugs in accordance with regulations , Transportation, temperature and humidity monitoring, tampering with computer system, temperature and humidity monitoring system data, concealing real drug purchase and sales records, bills, vouchers, and data; investigation of illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store drugs in accordance with regulations , Transportation, temperature and humidity monitoring, tampering with computer system, temperature and humidity monitoring system data, concealing real drug purchase and sales records, bills, vouchers, and data; investigation of illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Anhui: In accordance with the unified deployment of the State Administration, focusing on drug wholesalers, drug retail companies, drug users, drug tripartite logistics companies and other entities, focusing on "calling tickets", computer system data inauthentic, illegal channel purchases, and illegal sales of prescription drugs , Licensed pharmacists, illegal recycling of drugs and packaging, illegal operation of drugs containing stimulants, etc.
to carry out special treatment.
to carry out special treatment.
Liaoning: Random inspections of pharmaceutical companies in Shenyang will be conducted at a rate of 50%, and full coverage inspections will be conducted in other regions.
Supervise and inspect the implementation of laws pharmnet.
com.
cn/" target="_blank">and regulations and related quality management practices by pharmaceutical business enterprises, and conduct supervision and inspection of key varieties such as vaccines, special drugs, drugs selected for centralized procurement by the state, and Chinese herbal medicine pieces, purchase and sales channels, cold chain storage and transportation, "unified procurement and distribution", and personnel and other key aspects of performance of their duties, special drugs business enterprises , retail chain headquarters and other key enterprises, the implementation of key checks.
Supervise and inspect the implementation of laws pharmnet.
com.
cn/" target="_blank">and regulations and related quality management practices by pharmaceutical business enterprises, and conduct supervision and inspection of key varieties such as vaccines, special drugs, drugs selected for centralized procurement by the state, and Chinese herbal medicine pieces, purchase and sales channels, cold chain storage and transportation, "unified procurement and distribution", and personnel and other key aspects of performance of their duties, special drugs business enterprises , retail chain headquarters and other key enterprises, the implementation of key checks.
Medical Network News, March 15 In 2021, retail pharmacies will usher in the strictest inspections and strictest penalties.
Multi-departmental cooperation, will check pharmacies together
On March 12, the official WeChat account of the Jiangsu Provincial Food and Drug Administration announced the "Key Points of Provincial Drug Supervision in 2021" (hereinafter referred to as "Key Points"), and clearly defined the need to regulate the business and use of drugs to ensure the safety of drug use by the masses.
The "Key Points" pointed out that in view of the standardization of purchase and sales channels, business processes, and storage conditions, the supervision of business and use links should be strengthened.
Strengthen the supervision and inspection of pharmacists' on-the-job, prescription drug sales and other links, and increase the supervision of private medical institutions, plastic and cosmetic medical institutions, individual clinics, and maternal and child products specialty stores.
Strengthen the supervision and inspection of pharmacists' on-the-job, prescription drug sales and other links, and increase the supervision of private medical institutions, plastic and cosmetic medical institutions, individual clinics, and maternal and child products specialty stores.
At the same time, "Key Points" talked about the need to implement the regulatory requirements for drug business and use under the provincial bureau's new system, strengthen the business guidance for grassroots work, and establish and improve the contact point system for drug and device business and use supervision.
Coordinate the use of supervisory resources, organize supervision, inspection and spot checks on operating companies and users, and explore the key points of a unified inspection system across the province in areas such as retail pharmacies.
Coordinate the use of supervisory resources, organize supervision, inspection and spot checks on operating companies and users, and explore the key points of a unified inspection system across the province in areas such as retail pharmacies.
In addition, the "Key Points" also emphasized to strengthen external communication and coordination with health , public security, medical insurance and other departments, promote internal collaboration and linkage between inspection sub-bureaus and city and county supervision bureaus, and establish a joint inspection and information notification mechanism.
Pharmacy, the strictest inspection and punishment are coming
Cyber Blue-a pharmacy manager combed and found that up to now, 5 provinces have issued documents clarifying the inspection of retail pharmacies in 2021.
It is worth noting that, judging from the target requirements and arrangements announced by the provinces, the inspections of retail pharmacies by the regulatory authorities this year may be nationwide.
It is worth noting that, judging from the target requirements and arrangements announced by the provinces, the inspections of retail pharmacies by the regulatory authorities this year may be nationwide.
On the 5th of this month, Zhejiang Food and Drug Administration issued the "Notice on Organizing and Carrying out Unannounced Inspections of Drugs GSP in 2021.
" The Zhejiang Province notice clearly states that it is a work formulated in accordance with the requirements of the 2021 National Drug Registration Management and Post-Marketing Regulatory Work Conference and the provincial bureau's key work arrangements for 2021.
" The Zhejiang Province notice clearly states that it is a work formulated in accordance with the requirements of the 2021 National Drug Registration Management and Post-Marketing Regulatory Work Conference and the provincial bureau's key work arrangements for 2021.
Shanxi Province’s "Notice on the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021" also talked about resolutely implementing the "four most stringent" regulatory requirements, in accordance with the National Drug Registration Management and Post-Marketing Regulatory Work Conference and the provincial drug regulatory and party style The clean government construction work conference is arranged and deployed to prevent risks, ensure safety, strengthen supervision and promote development, and effectively ensure the safety of people's drug use.
In addition, it is worth mentioning that, judging from the documents issued by Zhejiang, Shanxi, Anhui and other provinces, the focus is on the fundamental orientation of the “four strictest”, which also means that this year’s inspections and penalties will be very strict.
If the pharmacy violates the regulations, it will be severely fined.
If the pharmacy violates the regulations, it will be severely fined.
Many provinces have issued documents, and the inspection will start soon
The author sorted out the key points and requirements for the renovation of retail pharmacies based on the documents of various provinces.
According to the work arrangement and plan, the inspection of retail pharmacies will begin this year.
The key points are as follows:
According to the work arrangement and plan, the inspection of retail pharmacies will begin this year.
The key points are as follows:
Zhejiang: Unannounced inspections of retail companies are organized and arranged by local organizations; focus on inspections of pharmaceutical retail companies in rural areas of the urban-rural fringe, and pharmaceutical retail companies that carry out online ordering stores and online ordering stores.
The focus of the inspection is the following 11 major behaviors:
The focus of the inspection is the following 11 major behaviors:
1.
Whether the traceability system of key products (vaccine, special management drugs, blood products, national centralized procurement drugs) is complete;
Whether the traceability system of key products (vaccine, special management drugs, blood products, national centralized procurement drugs) is complete;
2.
Quality risk control involving counterfeit and inferior drugs (business scope, automatic control of drug expiration date, near-effective drug inventory management, etc.
), whether the inspection of drug packaging and properties is performed in strict accordance with the requirements of GSP;
Quality risk control involving counterfeit and inferior drugs (business scope, automatic control of drug expiration date, near-effective drug inventory management, etc.
), whether the inspection of drug packaging and properties is performed in strict accordance with the requirements of GSP;
3.
Whether to provide premises, qualification certificates, bills and other conditions for others to illegally trade drugs; purchase from individuals or units without "Drug Production License" and "Drug Distribution License", enterprises or institutions without "Drug Registration Certificate" Drugs; selling drugs to units or individuals without legal qualifications, knowing or ought to know that others are engaged in unlicensed business and still providing drugs for them;
Whether to provide premises, qualification certificates, bills and other conditions for others to illegally trade drugs; purchase from individuals or units without "Drug Production License" and "Drug Distribution License", enterprises or institutions without "Drug Registration Certificate" Drugs; selling drugs to units or individuals without legal qualifications, knowing or ought to know that others are engaged in unlicensed business and still providing drugs for them;
4.
Whether the person in charge of corporate quality and quality management personnel perform their duties; whether the licensed pharmacist is certified;
Whether the person in charge of corporate quality and quality management personnel perform their duties; whether the licensed pharmacist is certified;
5.
The company's cold chain drug management, whether the drug storage and transportation records are complete and true; whether the drug storage, transportation, and temperature and humidity monitoring are not performed in accordance with regulations; whether the temperature and humidity data of cold storage and refrigerated trucks can be uploaded in real time;
The company's cold chain drug management, whether the drug storage and transportation records are complete and true; whether the drug storage, transportation, and temperature and humidity monitoring are not performed in accordance with regulations; whether the temperature and humidity data of cold storage and refrigerated trucks can be uploaded in real time;
6.
Whether to falsify the source of drug purchases, fabricate the flow of drug sales, tamper with the computer system, temperature and humidity monitoring system data, conceal the real drug purchase and sale records, bills, vouchers, data, etc.
, the drug purchase and sale records are incomplete, untrue, and business operations cannot be performed Retrospective
Whether to falsify the source of drug purchases, fabricate the flow of drug sales, tamper with the computer system, temperature and humidity monitoring system data, conceal the real drug purchase and sale records, bills, vouchers, data, etc.
, the drug purchase and sale records are incomplete, untrue, and business operations cannot be performed Retrospective
7.
When purchasing and selling drugs, certificates (licenses), tickets (invoices, bills accompanying the goods), accounts (physical accounts, financial accounts), goods (physical drugs), and payments (payments) cannot correspond to each other; the drugs are not in the warehouse , Set up off-book accounts, drugs are not included in the enterprise quality management system, use bank personal accounts for business transactions, etc.
;
When purchasing and selling drugs, certificates (licenses), tickets (invoices, bills accompanying the goods), accounts (physical accounts, financial accounts), goods (physical drugs), and payments (payments) cannot correspond to each other; the drugs are not in the warehouse , Set up off-book accounts, drugs are not included in the enterprise quality management system, use bank personal accounts for business transactions, etc.
;
8.
Whether the drug is stored in a place other than the approved address; whether the registered address, business method, and business scope are sold without authorization;
Whether the drug is stored in a place other than the approved address; whether the registered address, business method, and business scope are sold without authorization;
9.
Failing to monitor the temperature and humidity of the storage and transportation of drugs in accordance with regulations;
Failing to monitor the temperature and humidity of the storage and transportation of drugs in accordance with regulations;
10.
Retail companies have problems selling prescription drugs and recalling drugs in violation of regulations;
Retail companies have problems selling prescription drugs and recalling drugs in violation of regulations;
11.
Other violations of laws and regulations.
Other violations of laws and regulations.
Shanxi: Pharmaceutical retail companies focus on prescription drugs, Chinese herbal medicines, and cold chain drugs.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store drugs in accordance with regulations , Transportation, temperature and humidity monitoring, tampering with computer system, temperature and humidity monitoring system data, concealing real drug purchase and sales records, bills, vouchers, and data; investigation of illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store drugs in accordance with regulations , Transportation, temperature and humidity monitoring, tampering with computer system, temperature and humidity monitoring system data, concealing real drug purchase and sales records, bills, vouchers, and data; investigation of illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Anhui: In accordance with the unified deployment of the State Administration, focusing on drug wholesalers, drug retail companies, drug users, drug tripartite logistics companies and other entities, focusing on "calling tickets", computer system data inauthentic, illegal channel purchases, and illegal sales of prescription drugs , Licensed pharmacists, illegal recycling of drugs and packaging, illegal operation of drugs containing stimulants, etc.
to carry out special treatment.
to carry out special treatment.
Liaoning: Random inspections of pharmaceutical companies in Shenyang will be conducted at a rate of 50%, and full coverage inspections will be conducted in other regions.
Supervise and inspect the implementation of laws pharmnet.
com.
cn/" target="_blank">and regulations and related quality management practices by pharmaceutical business enterprises, and conduct supervision and inspection of key varieties such as vaccines, special drugs, drugs selected for centralized procurement by the state, and Chinese herbal medicine pieces, purchase and sales channels, cold chain storage and transportation, "unified procurement and distribution", and personnel and other key aspects of performance of their duties, special drugs business enterprises , retail chain headquarters and other key enterprises, the implementation of key checks.
Supervise and inspect the implementation of laws pharmnet.
com.
cn/" target="_blank">and regulations and related quality management practices by pharmaceutical business enterprises, and conduct supervision and inspection of key varieties such as vaccines, special drugs, drugs selected for centralized procurement by the state, and Chinese herbal medicine pieces, purchase and sales channels, cold chain storage and transportation, "unified procurement and distribution", and personnel and other key aspects of performance of their duties, special drugs business enterprises , retail chain headquarters and other key enterprises, the implementation of key checks.
Medical Network News, March 15 In 2021, retail pharmacies will usher in the strictest inspections and strictest penalties.
Multi-departmental cooperation, will check pharmacies together
Multi-sectoral joint will be checked with pharmacy pharmacy pharmacy On March 12, the official WeChat account of the Jiangsu Provincial Food and Drug Administration announced the "Key Points of Provincial Drug Supervision in 2021" (hereinafter referred to as "Key Points"), and clearly defined the need to regulate the business and use of drugs to ensure the safety of drug use by the masses.
The "Key Points" pointed out that in view of the standardization of purchase and sales channels, business processes, and storage conditions, the supervision of business and use links should be strengthened.
Strengthen the supervision and inspection of pharmacists' on-the-job, prescription drug sales and other links, and increase the supervision of private medical institutions, plastic and cosmetic medical institutions, individual clinics, and maternal and child products specialty stores.
Strengthen the supervision and inspection of pharmacists' on-the-job, prescription drug sales and other links, and increase the supervision of private medical institutions, plastic and cosmetic medical institutions, individual clinics, and maternal and child products specialty stores.
At the same time, "Key Points" talked about the need to implement the regulatory requirements for drug business and use under the provincial bureau's new system, strengthen the business guidance for grassroots work, and establish and improve the contact point system for drug and device business and use supervision.
Coordinate the use of supervisory resources, organize supervision, inspection and spot checks on operating companies and users, and explore the key points of a unified inspection system across the province in areas such as retail pharmacies.
Coordinate the use of supervisory resources, organize supervision, inspection and spot checks on operating companies and users, and explore the key points of a unified inspection system across the province in areas such as retail pharmacies.
In addition, the "Key Points" also emphasized to strengthen external communication and coordination with health , public security, medical insurance and other departments, promote internal collaboration and linkage between inspection sub-bureaus and city and county supervision bureaus, and establish a joint inspection and information notification mechanism.
Healthy, healthy, healthy Pharmacy, the strictest inspection and punishment are coming
Pharmacy, the strictest inspection and punishment are coming Cyber Blue-a pharmacy manager combed and found that up to now, 5 provinces have issued documents clarifying the inspection of retail pharmacies in 2021.
It is worth noting that, judging from the target requirements and arrangements announced by the provinces, the inspections of retail pharmacies by the regulatory authorities this year may be nationwide.
It is worth noting that, judging from the target requirements and arrangements announced by the provinces, the inspections of retail pharmacies by the regulatory authorities this year may be nationwide.
On the 5th of this month, Zhejiang Food and Drug Administration issued the "Notice on Organizing and Carrying out Unannounced Inspections of Drugs GSP in 2021.
" The Zhejiang Province notice clearly states that it is a work formulated in accordance with the requirements of the 2021 National Drug Registration Management and Post-Marketing Regulatory Work Conference and the provincial bureau's key work arrangements for 2021.
" The Zhejiang Province notice clearly states that it is a work formulated in accordance with the requirements of the 2021 National Drug Registration Management and Post-Marketing Regulatory Work Conference and the provincial bureau's key work arrangements for 2021.
Shanxi Province’s "Notice on the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021" also talked about resolutely implementing the "four most stringent" regulatory requirements, in accordance with the National Drug Registration Management and Post-Marketing Regulatory Work Conference and the provincial drug regulatory and party style The clean government construction work conference is arranged and deployed to prevent risks, ensure safety, strengthen supervision and promote development, and effectively ensure the safety of people's drug use.
In addition, it is worth mentioning that, judging from the documents issued by Zhejiang, Shanxi, Anhui and other provinces, the focus is on the fundamental orientation of the “four strictest”, which also means that this year’s inspections and penalties will be very strict.
If the pharmacy violates the regulations, it will be severely fined.
If the pharmacy violates the regulations, it will be severely fined.
Many provinces have issued documents, and the inspection will start soon
Many provinces have issued documents, and the inspection will start soon The author sorted out the key points and requirements for the renovation of retail pharmacies based on the documents of various provinces.
According to the work arrangement and plan, the inspection of retail pharmacies will begin this year.
The key points are as follows:
According to the work arrangement and plan, the inspection of retail pharmacies will begin this year.
The key points are as follows:
Zhejiang: Unannounced inspections of retail companies are organized and arranged by local organizations; focus on inspections of pharmaceutical retail companies in rural areas of the urban-rural fringe, and pharmaceutical retail companies that carry out online ordering stores and online ordering stores.
The focus of the inspection is the following 11 major behaviors:
The focus of the inspection is the following 11 major behaviors:
1.
Whether the traceability system of key products (vaccine, special management drugs, blood products, national centralized procurement drugs) is complete;
Whether the traceability system of key products (vaccine, special management drugs, blood products, national centralized procurement drugs) is complete;
2.
Quality risk control involving counterfeit and inferior drugs (business scope, automatic control of drug expiration date, near-effective drug inventory management, etc.
), whether the inspection of drug packaging and properties is performed in strict accordance with the requirements of GSP;
Quality risk control involving counterfeit and inferior drugs (business scope, automatic control of drug expiration date, near-effective drug inventory management, etc.
), whether the inspection of drug packaging and properties is performed in strict accordance with the requirements of GSP;
3.
Whether to provide premises, qualification certificates, bills and other conditions for others to illegally trade drugs; purchase from individuals or units without "Drug Production License" and "Drug Distribution License", enterprises or institutions without "Drug Registration Certificate" Drugs; selling drugs to units or individuals without legal qualifications, knowing or ought to know that others are engaged in unlicensed business and still providing drugs for them;
Whether to provide premises, qualification certificates, bills and other conditions for others to illegally trade drugs; purchase from individuals or units without "Drug Production License" and "Drug Distribution License", enterprises or institutions without "Drug Registration Certificate" Drugs; selling drugs to units or individuals without legal qualifications, knowing or ought to know that others are engaged in unlicensed business and still providing drugs for them;
4.
Whether the person in charge of corporate quality and quality management personnel perform their duties; whether the licensed pharmacist is certified;
Whether the person in charge of corporate quality and quality management personnel perform their duties; whether the licensed pharmacist is certified;
5.
The company's cold chain drug management, whether the drug storage and transportation records are complete and true; whether the drug storage, transportation, and temperature and humidity monitoring are not performed in accordance with regulations; whether the temperature and humidity data of cold storage and refrigerated trucks can be uploaded in real time;
The company's cold chain drug management, whether the drug storage and transportation records are complete and true; whether the drug storage, transportation, and temperature and humidity monitoring are not performed in accordance with regulations; whether the temperature and humidity data of cold storage and refrigerated trucks can be uploaded in real time;
6.
Whether to falsify the source of drug purchases, fabricate the flow of drug sales, tamper with the computer system, temperature and humidity monitoring system data, conceal the real drug purchase and sale records, bills, vouchers, data, etc.
, the drug purchase and sale records are incomplete, untrue, and business operations cannot be performed Retrospective
Whether to falsify the source of drug purchases, fabricate the flow of drug sales, tamper with the computer system, temperature and humidity monitoring system data, conceal the real drug purchase and sale records, bills, vouchers, data, etc.
, the drug purchase and sale records are incomplete, untrue, and business operations cannot be performed Retrospective
7.
When purchasing and selling drugs, certificates (licenses), tickets (invoices, bills accompanying the goods), accounts (physical accounts, financial accounts), goods (physical drugs), and payments (payments) cannot correspond to each other; the drugs are not in the warehouse , Set up off-book accounts, drugs are not included in the enterprise quality management system, use bank personal accounts for business transactions, etc.
;
When purchasing and selling drugs, certificates (licenses), tickets (invoices, bills accompanying the goods), accounts (physical accounts, financial accounts), goods (physical drugs), and payments (payments) cannot correspond to each other; the drugs are not in the warehouse , Set up off-book accounts, drugs are not included in the enterprise quality management system, use bank personal accounts for business transactions, etc.
;
8.
Whether the drug is stored in a place other than the approved address; whether the registered address, business method, and business scope are sold without authorization;
Whether the drug is stored in a place other than the approved address; whether the registered address, business method, and business scope are sold without authorization;
9.
Failing to monitor the temperature and humidity of the storage and transportation of drugs in accordance with regulations;
Failing to monitor the temperature and humidity of the storage and transportation of drugs in accordance with regulations;
10.
Retail companies have problems selling prescription drugs and recalling drugs in violation of regulations;
Retail companies have problems selling prescription drugs and recalling drugs in violation of regulations;
11.
Other violations of laws and regulations.
Other violations of laws and regulations.
Shanxi: Pharmaceutical retail companies focus on prescription drugs, Chinese herbal medicines, and cold chain drugs.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store drugs in accordance with regulations , Transportation, temperature and humidity monitoring, tampering with computer system, temperature and humidity monitoring system data, concealing real drug purchase and sales records, bills, vouchers, and data; investigation of illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Based on compliance inspections, they focus on purchasing drugs and recycling drugs through illegal channels; selling drugs beyond the scope of business; failing to store drugs in accordance with regulations , Transportation, temperature and humidity monitoring, tampering with computer system, temperature and humidity monitoring system data, concealing real drug purchase and sales records, bills, vouchers, and data; investigation of illegal behaviors such as non-compliance of prescription drug sales and "certification" of licensed pharmacists.
Anhui: In accordance with the unified deployment of the State Administration, focusing on drug wholesalers, drug retail companies, drug users, drug tripartite logistics companies and other entities, focusing on "calling tickets", computer system data inauthentic, illegal channel purchases, and illegal sales of prescription drugs , Licensed pharmacists, illegal recycling of drugs and packaging, illegal operation of drugs containing stimulants, etc.
to carry out special treatment.
to carry out special treatment.
Liaoning: Random inspections of pharmaceutical companies in Shenyang will be conducted at a rate of 50%, and full coverage inspections will be conducted in other regions.
Supervise and inspect the implementation of laws pharmnet.
com.
cn/" target="_blank">and regulations and related quality management practices by pharmaceutical business enterprises, and conduct supervision and inspection of key varieties such as vaccines, special drugs, drugs selected for centralized procurement by the state, and Chinese herbal medicine pieces, purchase and sales channels, cold chain storage and transportation, "unified procurement and distribution", and personnel and other key aspects of performance of their duties, special drugs business enterprises , retail chain headquarters and other key enterprises, the implementation of key checks.
pharmnet. Supervise and inspect the implementation of laws pharmnet.
com.
cn/" target="_blank">and regulations and related quality management practices by pharmaceutical business enterprises, and conduct supervision and inspection of key varieties such as vaccines, special drugs, drugs selected for centralized procurement by the state, and Chinese herbal medicine pieces, purchase and sales channels, cold chain storage and transportation, "unified procurement and distribution", and personnel and other key aspects of performance of their duties, special drugs business enterprises , retail chain headquarters and other key enterprises, the implementation of key checks.
com.
cn/" target="_blank">Lawspharmnet.
com.
cn/" target="_blank"> and regulations and regulations pharmaceutical drugs pharmaceutical companies business enterprises
